- Filed
- Aug 19, 2025 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 12, 2025 | 7.46M sh |
| Shares Diluted restated | Q1 2025 · Mar 31, 2025 | 4.78M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$9.47M |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $30.96M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $35.71M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $20.41M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $15.38M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −$69.79M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$77.98M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $15.9M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $18.86M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $108.2M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $110.79M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $33.17M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $27.16M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $38.41M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $32.81M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2025 | −$0.31 |
| Eps Basic restated | Q1 2025 · Mar 31, 2025 | −$0.31 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $5.2M |
| Rd Expense | Q1 2025 · Mar 31, 2025 | $2.62M |
| Net Income restated | Q1 2025 · Mar 31, 2025 | −$1.5M |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$7.28M |
| Gross Profit | Q1 2025 · Mar 31, 2025 | $4.16M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | $1.42M |
| Revenue | Q1 2025 · Mar 31, 2025 | $5.58M |